1 |
Chiu MJ, Chen TF, Yip PK, Hua MS, Tang LY. 2006. Behavioral and psychologic symptoms in different types of dementia. J Formos Med Assoc 105:556-562.
DOI
|
2 |
Choi JH, Lee EB, Jang HH, Cha YS, Park YS, Lee SH. 2021. Allium hookeri extracts improve scopolamine-induced cognitive impairment via activation of the cholinergic system and anti-neuroinflammation in mice. Nutrients 13:2890.
DOI
|
3 |
Collins SM, Surette M, Bercik P. 2012. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10:735-742.
DOI
|
4 |
Kaur H, Nagamoto-Combs K, Golovko S, Golovko MY, Klug MG, Combs CK. 2020b. Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer's disease. Neurobiol Aging 92:114-134.
DOI
|
5 |
Kim HY, Lee DK, Chung BR, Kim HV, Kim YS. 2016. Intracerebroventricular injection of amyloid-β peptides in normal mice to acutely induce Alzheimer-like cognitive deficits. J Vis Exp 109:e53308.
DOI
|
6 |
Kim Y, Kim J, He M, Lee A, Cho E. 2021b. Apigenin ameliorates scopolamine-induced cognitive dysfunction and neuronal damage in mice. Molecules 26:5192.
|
7 |
Kim H, Kim S, Park SJ, Park G, Shin H, Park MS, Kim J. 2021a. Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI improves cognitive and memory function in the mouse model of Alzheimer's disease. Front Aging Neurosci 13:709091.
|
8 |
Kobayashi Y, Sugahara H, Shimada K, Mitsuyama E, Kuhara T, Yasuoka A, Kondo T, Abe K, Xiao JZ. 2017. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease. Sci Rep 7:13510.
|
9 |
Konsman JP, Parnet P, Dantzer R. 2002. Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci 25:154-159.
DOI
|
10 |
Kumar A, Dogra S, Prakash A. 2009. Effect of carvedilol on behavioral, mitochondrial dysfunction, and oxidative damage against D-galactose induced senescence in mice. Naunyn Schmiedebergs Arch Pharmacol 380:431-441.
DOI
|
11 |
Kwon OY, Lee SH. 2020. Ameliorating activity of Ishige okamurae on the amyloid beta-induced cognitive deficits and neurotoxicity through regulating ERK, p38 MAPK, and JNK signaling in Alzheimer's disease-like mice model. Mol Nutr Food Res 64:e1901220.
|
12 |
Lee HJ, Lee KE, Kim JK, Kim DH. 2019. Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice. Sci Rep 9:11814.
|
13 |
Yang L, Zhou R, Tong Y, Chen P, Shen Y, Miao S, Liu X. 2020a. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation. Neurobiol Dis 140:104814.
|
14 |
Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, Lu D, Wei W, Wang Y, Li H, Fu Y, Zhu L. 2019. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep 9:5790.
|
15 |
Zhou H, Lapointe BM, Clark SR, Zbytnuik L, Kubes P. 2006. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol 177:8103-8110.
DOI
|
16 |
Lazareno S, Popham A, Birdsall NJM. 2000. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-3H]scopolamine and acetylcholine at muscarinic receptor subtypes: Identification of a second allosteric site. Mol Pharmacol 58:194-207.
DOI
|
17 |
Lee DY, Shin YJ, Kim JK, Jang HM, Joo MK, Kim DH. 2021. Alleviation of cognitive impairment by gut microbiota lipopolysaccharide production-suppressing Lactobacillus plantarum and Bifidobacterium longum in mice. Food Funct 12:10750-10763.
DOI
|
18 |
Lee HJ, Lim SM, Kim DH. 2018. Lactobacillus johnsonii CJLJ103 attenuates scopolamine-induced memory impairment in mice by increasing BDNF expression and inhibiting NF-κB activation. J Microbiol Biotechnol 28:1443-1446.
DOI
|
19 |
Liu Y, Liu Y, Guo Y, Xu L, Wang H. 2021. Phlorizin exerts potent effects against aging induced by D-galactose in mice and PC12 cells. Food Funct 12:2148-2160.
DOI
|
20 |
Kwon OY, Lee SH. 2021. Ishige okamurae suppresses trimethyltin-induced neurodegeneration and glutamate-mediated excitotoxicity by regulating MAPKs/Nrf2/HO-1 antioxidant pathways. Antioxidants 10:440.
|
21 |
Briguglio M, Dell'Osso B, Panzica G, Malgaroli A, Banfi G, Zanaboni Dina C, Galentino R, Porta M. 2018. Dietary neurotransmitters: A narrative review on current knowledge. Nutrients 10:591.
|
22 |
Bruel-Jungerman E, Lucassen PJ, Francis F. 2011. Cholinergic influences on cortical development and adult neurogenesis. Behav Brain Res 221:379-388.
DOI
|
23 |
Cheng LH, Chou PY, Hou AT, Huang CL, Shiu WL, Wang S. 2022. Lactobacillus paracasei PS23 improves cognitive deficits via modulating the hippocampal gene expression and the gut microbiota in D-galactose-induced aging mice. Food Funct 13:5240-5251.
DOI
|
24 |
Logsdon AF, Erickson MA, Rhea EM, Salameh TS, Banks WA. 2018. Gut reactions: How the blood-brain barrier connects the microbiome and the brain. Exp Biol Med 243:159-165.
DOI
|
25 |
Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, Yin M. 2013. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background. Neurosci Lett 557:84-89.
DOI
|
26 |
Cao J, Amakye WK, Qi C, Liu X, Ma J, Ren J. 2021. Bifidobacterium lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer's disease in the APP/PS1 mouse model. Eur J Nutr 60:3757-3769.
DOI
|
27 |
Christensen H, Mackinnon AJ, Korten AE, Jorm AF, Henderson AS, Jacomb P, Rodgers B. 1999. An analysis of diversity in the cognitive performance of elderly community dwellers: Individual differences in change scores as a function of age. Psychol Aging 14:365-379.
DOI
|
28 |
Panza F, Lozupone M, Solfrizzi V, Watling M, Imbimbo BP. 2019. Time to test antibacterial therapy in Alzheimer's disease. Brain 142:2905-2929.
|
29 |
Lopez-Sobaler AM, Lorenzo Mora AM, Salas Gonzalez MD, Peral Suarez A, Aparicio A, Ortega RM. 2021. Importance of choline in cognitive function. Nutr Hosp 37:18-23.
|
30 |
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. Neuron 39:409-421.
DOI
|
31 |
Parameshwaran K, Irwin MH, Steliou K, Pinkert CA. 2010. D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice. Rejuvenation Res 13:729-735.
DOI
|
32 |
Patel C, Pande S, Acharya S. 2020. Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice. Naunyn Schmiedebergs Arch Pharmacol 393:1955-1962.
DOI
|
33 |
Perry VH. 2004. The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease. Brain Behav Immun 18:407-413.
DOI
|
34 |
Petrella C, Strimpakos G, Torcinaro A, Middei S, Ricci V, Gargari G, Mora D, De Santa F, Farioli-Vecchioli S. 2021. Proneurogenic and neuroprotective effect of a multi strain probiotic mixture in a mouse model of acute inflammation:Involvement of the gut-brain axis. Pharmacol Res 172:105795.
|
35 |
Prakash A, Kumar A. 2013. Pioglitazone alleviates the mitochondrial apoptotic pathway and mito-oxidative damage in the dgalactose-induced mouse model. Clin Exp Pharmacol Physiol 40:644-651.
DOI
|
36 |
Rehman SU, Shah SA, Ali T, Chung JI, Kim MO. 2017. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats. Mol Neurobiol 54:255-271.
DOI
|
37 |
Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jaggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, Holscher C, Mathews PM, Jucker M. 2006. Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7:940-946.
DOI
|
38 |
Ramalho JB, Spiazzi CC, Bicca DF, Rodrigues JF, Sehn CP, da Silva WP, Cibin FWS. 2022. Beneficial effects of Lactococcus lactis subsp. cremoris LL95 treatment in an LPS-induced depression-like model in mice. Behav Brain Res 426:113847.
|
39 |
Ravi SK, Narasingappa RB, Vincent B. 2019. Neuro-nutrients as anti-Alzheimer's disease agents: A critical review. Crit Rev Food Sci Nutr 59:2999-3018.
DOI
|
40 |
Shoemark DK, Allen SJ. 2015. The microbiome and disease: Reviewing the links between the oral microbiome, aging, and Alzheimer's disease. J Alzheimers Dis 43:725-738.
DOI
|
41 |
Shwe T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. 2018. Role of D-galactose-induced brain aging and its potential used for therapeutic interventions. Exp Gerontol 101:13-36.
DOI
|
42 |
Stover KR, Campbell MA, Van Winssen CM, Brown RE. 2015. Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease. Behav Brain Res 289:29-38.
DOI
|
43 |
Mohammadi G, Dargahi L, Peymani A, Mirzanejad Y, Alizadeh SA, Naserpour T, Nassiri-Asl M. 2019. The effects of probiotic formulation pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a lipopolysaccharide rat model. J Am Coll Nutr 38:209-217.
DOI
|
44 |
Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC. 2014. Single App knock-in mouse models of Alzheimer's disease. Nat Neurosci 17:661-663.
DOI
|
45 |
Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF. 2010. Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis. Brain Pathol 20:598-612.
DOI
|
46 |
MacIntyre A, Abramov R, Hammond CJ, Hudson AP, Arking EJ, Little CS, Appelt DM, Balin BJ. 2003. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res 71:740-750.
DOI
|
47 |
Maia LF, Kaeser SA, Reichwald J, Hruscha M, Martus P, Staufenbiel M, Jucker M. 2013. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci Transl Med 5:194re2.
|
48 |
Mehla J, Lacoursiere SG, Lapointe V, McNaughton BL, Sutherland RJ, McDonald RJ, Mohajerani MH. 2019. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APPNL-G-F/NL-G-F) model of Alzheimer's disease. Neurobiol Aging 75:25-37.
DOI
|
49 |
Miyamoto M, Kiyota Y, Nishiyama M, Nagaoka A. 1992. Senescence-accelerated mouse (SAM): Age-related reduced anxiety-like behavior in the SAM-P/8 strain. Physiol Behav 51:979-985.
DOI
|
50 |
Miyamoto M, Kiyota Y, Yamazaki N, Nagaoka A, Matsuo T, Nagawa Y, Takeda T. 1986. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav 38:399-406.
DOI
|
51 |
Morais LH, Schreiber HL IV, Mazmanian SK. 2021. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol 19:241-255.
DOI
|
52 |
Morley JE, Armbrecht HJ, Farr SA, Kumar VB. 2012. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis 1822:650-656.
DOI
|
53 |
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. 1992. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1:345-347.
DOI
|
54 |
Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L. 2001. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 4:887-893.
DOI
|
55 |
Banks WA, Farr SA, Morley JE. 2002. Entry of blood-borne cytokines into the central nervous system: Effects on cognitive processes. Neuroimmunomodulation 10:319-327.
DOI
|
56 |
Akter R, Chowdhury MAR, Rahman MH. 2021. Flavonoids and polyphenolic compounds as potential talented agents for the treatment of Alzheimer's disease and their antioxidant activities. Curr Pharm Des 27:345-356.
DOI
|
57 |
Ali T, Yoon GH, Shah SA, Lee HY, Kim MO. 2015. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. Sci Rep 5:11708.
|
58 |
Alladi S, Mekala S, Chadalawada SK, Jala S, Mridula R, Kaul S. 2011. Subtypes of dementia: A study from a memory clinic in India. Dement Geriatr Cogn Disord 32:32-38.
DOI
|
59 |
Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B. 1999. TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs. FASEB J 13:63-68.
DOI
|
60 |
Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, Fiorini D, Boarelli MC, Rossi G, Eleuteri AM. 2017. Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep 7:2426.
|
61 |
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB. 2021. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci USA 118:e2102191118.
|
62 |
Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. 2006. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J Neurosci 26:10129-10140.
DOI
|
63 |
Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I. 1998. Functional food science and gastrointestinal physiology and function. Br J Nutr 80:S147-S171.
DOI
|
64 |
Bowler JV, Munoz DG, Merskey H, Hachinski V. 1998. Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 64:18-24.
DOI
|
65 |
Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P. 1992. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89:10075-10078.
DOI
|
66 |
Sun J, Xu J, Yang B, Chen K, Kong Y, Fang N, Gong T, Wang F, Ling Z, Liu J. 2019. Effect of Clostridium butyricum against microglia-mediated neuroinflammation in Alzheimer's disease via regulating gut microbiota and metabolites butyrate. Mol Nutr Food Res 64:1900636.
|
67 |
Van Erum J, Van Dam D, De Deyn PP. 2019. Alzheimer's disease: Neurotransmitters of the sleep-wake cycle. Neurosci Biobehav Rev 105:72-80.
DOI
|
68 |
Vitetta L, Briskey D, Hayes E, Shing C, Peake J. 2012. A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology 20:251-266.
DOI
|
69 |
Wang QJ, Shen YE, Wang X, Fu S, Zhang X, Zhang YN, Wang RT. 2020. Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice. Aging 12:628-649.
DOI
|
70 |
Whitehouse PJ, Price DL, Clark AW, Coyle JT, Delong MR. 1981. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126.
DOI
|
71 |
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delong MR. 1982. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237-1239.
DOI
|
72 |
Yadang FSA, Nguezeye Y, Kom CW, Betote PHD, Mamat A, Tchokouaha LRY, Taiwe GS, Agbor GA, Bum EN. 2020. Scopolamine-induced memory impairment in mice: Neuroprotective effects of Carissa edulis (Forssk.) Valh (Apocynaceae) aqueous extract. Int J Alzheimers Dis 2020:6372059.
|
73 |
Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T. 1981. A new murine model of accelerated senescence. Mech Ageing Dev 17:183-194.
DOI
|
74 |
Deng X, Zhao S, Liu X, Han L, Wang R, Hao H, Jiao Y, Han S, Bai C. 2020. Polygala tenuifolia: A source for antialzheimer's disease drugs. Pharm Biol 58:410-416.
DOI
|
75 |
Devi L, Ohno M. 2010. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLOS ONE 5:e12974.
|
76 |
Song X, Zhao Z, Zhao Y, Jin Q, Li S. 2022. Protective effects of Bacillus coagulans JA845 against D-galactose/AlCl3-induced cognitive decline, oxidative stress and neuroinflammation. J Microbiol Biotechnol 32:212-219.
DOI
|
77 |
Vitetta L, Vitetta G, Hall S. 2018. Immunological tolerance and function: Associations between intestinal bacteria, probiotics, prebiotics, and phages. Front Immunol 9:2240.
|
78 |
Zhu G, Zhao J, Zhang H, Chen W, Wang G. 2021. Administration of Bifidobacterium breve improves the brain function of Aβ1-42-treated mice via the modulation of the gut microbiome. Nutrients 13:1602.
DOI
|
79 |
Webberley TS, Masetti G, Bevan RJ, Kerry-Smith J, Jack AA, Michael DR, Thomas S, Glymenaki M, Li J, McDonald JAK, John D, Morgan JE, Marchesi JR, Good MA, Plummer SF, Hughes TR. 2022. The impact of probiotic supplementation on cognitive, pathological and metabolic markers in a transgenic mouse model of Alzheimer's disease. Front Neurosci 16:843105.
|
80 |
Yang X, Yu D, Xue L, Li H, Du J. 2020b. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B 10:475-487.
DOI
|
81 |
Woo JY, Gu W, Kim KA, Jang SE, Han MJ, Kim DH. 2014. Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a D-galactose-induced accelerated aging mouse model. Anaerobe 27:22-26.
DOI
|
82 |
Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, Gomez-Isla T, Hernandez I, Lleo A, Machado A, Martinez-Lage P, Masdeu J, Molina-Porcel L, Molinuevo JL, Pastor P, Perez-Tur J, Relvas R, Oliveira CR, Ribeiro MH, Rogaeva E, Sa A, Samaranch L, Sanchez-Valle R, Santana I, Tarraga L, Valdivieso F, Singleton A, Hardy J, Clarimon J. 2010. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging 31:725-731.
DOI
|
83 |
Kamdi SP, Raval A, Nakhate KT. 2021. Phloridzin attenuates lipopolysaccharide-induced cognitive impairment via antioxidant, anti-inflammatory and neuromodulatory activities. Cytokine 139:155408.
|
84 |
Kaur H, Golovko S, Golovko MY, Singh S, Darland DC, Combs CK. 2020a. Effects of probiotic supplementation on short chain fatty acids in the AppNL-G-F mouse model of Alzheimer's disease. J Alzheimers Dis 76:1083-1102.
DOI
|